Table 1 Subject characteristics
IFN-α 2b-treated patients with melanoma | Untreated patients with melanoma | Healthy subjects | IFN-α 2b therapy, n (%) | ||
|---|---|---|---|---|---|
Adjuvant | Neoadjuvant | ||||
Subjects, n | 22 | 22 | 20 | ||
Mean age, years | 43.0 | 43.5 | 44.8 | ||
Sex, n (%) | |||||
Male | 12 (55) | 10 | 13 | ||
Female | 10 (45) | 12 | 7 | ||
Melanoma stage, n (%) | |||||
I | N/A | 4 (18.3) | N/A | N/A | N/A |
II | N/A | 2 (9.2) | N/A | N/A | N/A |
IIIA | 12 (54.5) | 2* (9.2) | N/A | 12 (54.5) | 0 |
IIIC | 3 (13.7) | 4* (18.3) | N/A | 1 (4.5) | 2 (9.1) |
IV | 7 (31.8) | 10 (45) | N/A | 4 (18.2) | 3 (13.7) |